|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.110 USD | +0.39% |
|
-1.73% | +2.20% |
| Jan. 20 | Medical Properties Trust to Change Ticker Symbol to MPT | MT |
| Nov. 18 | National Healthcare Properties announces Andrew Babin as Chief Financial Officer | RE |
| Capitalization | 3.07B 2.61B 2.42B 2.26B 4.22B 282B 4.47B 27.69B 10.99B 133B 11.53B 11.29B 485B | P/E ratio 2025 * |
-10.8x | P/E ratio 2026 * | 45.6x |
|---|---|---|---|---|---|
| Enterprise value | 12.03B 10.23B 9.48B 8.86B 16.52B 1,105B 17.51B 108B 43.03B 522B 45.11B 44.19B 1,898B | EV / Sales 2025 * |
12.6x | EV / Sales 2026 * | 11.5x |
| Free-Float |
86.63% | Yield 2025 * |
6.33% | Yield 2026 * | 6.65% |
Last Transcript: Medical Properties Trust, Inc.
| 1 day | +0.39% | ||
| 1 week | -1.73% | ||
| Current month | +2.20% | ||
| 1 month | +1.79% | ||
| 3 months | +0.99% | ||
| 6 months | +18.01% | ||
| Current year | +2.20% |
| 1 week | 5.02 | 5.28 | |
| 1 month | 4.98 | 5.58 | |
| Current year | 4.98 | 5.58 | |
| 1 year | 3.95 | 6.34 | |
| 3 years | 2.92 | 13.7 | |
| 5 years | 2.92 | 24.13 | |
| 10 years | 2.92 | 24.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Hamner
DFI | Director of Finance/CFO | 69 | 2003-08-31 |
Edward Aldag
CEO | Chief Executive Officer | 62 | 2003-08-26 |
Rosa Hooper
COO | Chief Operating Officer | 65 | 2023-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Aldag
CHM | Chairman | 62 | 2003-08-26 |
G. Dawson
BRD | Director/Board Member | 68 | 2004-03-31 |
Richard Hamner
BRD | Director/Board Member | 69 | 2004-12-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.39% | -1.73% | +11.82% | -62.92% | 3.07B | ||
| +0.95% | -4.02% | +38.90% | +147.28% | 126B | ||
| +0.54% | -1.86% | +29.53% | +51.88% | 36.16B | ||
| +1.04% | -2.28% | +17.89% | +52.26% | 12.91B | ||
| +1.63% | +1.40% | -12.45% | -33.80% | 12.56B | ||
| -0.54% | -3.69% | +61.06% | - | 8.24B | ||
| +0.85% | -2.41% | +38.01% | +88.59% | 8.23B | ||
| +0.77% | -0.98% | +2.21% | -20.88% | 6.01B | ||
| -1.37% | -1.42% | +32.57% | +113.72% | 4.72B | ||
| -1.05% | -2.18% | +12.36% | +41.40% | 4.69B | ||
| Average | +0.32% | -1.67% | +23.19% | +41.95% | 22.27B | |
| Weighted average by Cap. | +0.76% | -2.35% | +31.99% | +101.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 952M 809M 750M 701M 1.31B 87.43B 1.39B 8.57B 3.4B 41.28B 3.57B 3.5B 150B | 1.02B 865M 802M 749M 1.4B 93.46B 1.48B 9.16B 3.64B 44.13B 3.81B 3.74B 161B |
| Net income | -286M -243M -225M -211M -392M -26.26B -416M -2.57B -1.02B -12.4B -1.07B -1.05B -45.1B | 62.73M 53.36M 49.45M 46.21M 86.15M 5.76B 91.32M 565M 224M 2.72B 235M 230M 9.9B |
| Net Debt | 8.96B 7.62B 7.06B 6.6B 12.3B 823B 13.04B 80.69B 32.03B 389B 33.58B 32.9B 1,413B | 8.63B 7.34B 6.8B 6.36B 11.85B 793B 12.56B 77.75B 30.87B 374B 32.36B 31.7B 1,362B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-23 | 5.110 $ | +0.39% | 5,469,965 |
| 26-01-22 | 5.090 $ | -2.12% | 5,372,979 |
| 26-01-21 | 5.200 $ | +1.17% | 5,394,878 |
| 26-01-20 | 5.140 $ | -1.15% | 8,411,430 |
| 26-01-16 | 5.200 $ | +0.78% | 5,448,602 |
Delayed Quote Nyse, January 23, 2026 at 04:00 pm EST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MPW Stock
Select your edition
All financial news and data tailored to specific country editions
















